P.M. Rao's research while affiliated with Long Island University and other places
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publication (1)
Purpose
The purpose of this paper, focusing mainly on India – and a lesser extent on China – is to examine, broadly, two related issues concerning the rise of pharmaceutical industry in the emerging economies: the strategic response of the emerging‐country pharmaceutical firms to the new patent regime that recognizes and enforces product patents; a...
Citations
... Foreign businesses possessed almost 99 percent of all pharmaceutical patents in India at the time, and domestic Indian medicine costs were among the highest in the world [3]. From the 1960s until the government implemented policies emphasizing self-sufficiency and employing local production the pharma business in India remained import-dependent (Rao, 2008) [4]. The stringent government reforms including the elimination of product patents through the Patent Act, 1970 on pharmaceuticals, agricultural products, and atomic energy and price limitations on some formulations and bulk drugs through the Drug Price Control Order (DPCO), 1970 led to the withdrawal of MNCs from Indian Pharma market. ...
